Adrenocortical Steroids Flashcards

1
Q

Of hormones produced by adrenal cortex, which produces negative FB to hypothalamus?

A

only Glucocorticoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What controls mineralcorticoid levels?

A

-K and Angiotensin II

plus ACTH to a lesser extent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What controls glucocorticoids and androgens from adrenal glands?

A

ACTH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the rate-limiting step in the synthesis of hormones from the adrenal cortex?

A

conversion of cholesterol to pregnenolone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

cortisol

A

has both GC and MC activity

  • DOA 8-12 h
  • replacement therapy and emergencies (chronic or acute adrenal insufficiency)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

prednisolone

A

increased GC and decreased MC activity
-DOA 12-36 h
systempic anti-inflammatory effects and immunosuppressive effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

fludrocortisone

A

increased MC activity

-DOC for replacing MC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

dexamethasone

A
  • no MC activity

- systemic anti-inflammatory and immunosuppressive effects, used when water retention is undesirable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

uses of GC in non-adrenal d/o

A
  • lung maturation before birth
  • suppressing immune system for organ transplantation
  • rx of childhood ALL (with methotrexate)
  • suppress immune system for symptomatic rx of inflammatory and/or immune d/o
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

SE of GC

A
  • few when used topically or systemically for 2 weeks of high doses:
  • hyperglycemia/glycosuria
  • increased PRO breakdown
  • increased risk of infections
  • myopathy
  • osteoporosis
  • behavioral changes
  • cataracts
  • ulcers
  • sodium and fluid retention, loss of K (not all due to MC effect)
  • hypertension
  • growth retardation in children
  • suppression of HPA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

effects of w/d from GC

A
  • flare up of underlying disease being rx

- adrenal insufficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

minimizing SE of GC

A
  • consider risk/benefit ratio
  • use smallest dose possible and check periodically
  • alternate day admin: alleviates suppression of the HPA axis
  • administer together with newer immunosuppressants
  • modify diet: high K, low Na, high PRO, incr Vit D and Ca
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

use of mineralocorticoids

A

-only useful as rx of adrenal insufficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

SE of fludrocortisone

A
  • Fluid and electrolyte abnormalities

- HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

rx acute adrenal insufficiency

A

-GC and MC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

rx chronic adrenal insufficiency

A

-GC and MC or GC + salt

17
Q

Congenital adrenal hyperplasia -1

A

-alteration in CYP21A2 [21B hydroxylase), effects progesterone conversion to 11-deoxycorticosterone and 17 alpha OH progesterone –> 11-desoxycortisol. result: CRH, ACTH high bc dec GC and MC. Elevated androgens

18
Q

CAH-2

A
  • alteration in CYP11B1 (11B hydroxylase)

- end up with elevated 11-deoxycorticosterone, which acts as mineralcorticoid and inc androgens. dec cortisol.

19
Q

treatment of CAH

A
  • GC replacement therapy and to inhibit ACTH production by pituitary
  • MC and salt as replacement therapy when CAH-1
  • MC antagonists and salt restriction in CAH 2
  • antiandrogens to coutneract virilizing effects of increased androgen prod
20
Q

primary aldosteronism causes

A
  • adrenal adenoma, hyperplastic adrenals, or malignant tumors
  • common cuase of secondary HTN
21
Q

primary alderosteronism rx

A
  • rx with spironolactone, antagonist of the mineralocorticoid receptor (also an androgen antagonist)
  • eplenrenone, mineralocorticoid antagonist with no anti-androgen activity
22
Q

Cushing’s syndrome

A
  • increased cortisol prod due to primary adrenal defect or increased ACTH secretion (pituitary or other tissues)
  • hyperglycemia, HTN, fat redistribution, muscle wasting
23
Q

rx for cushing’s syndrome

A
  • surgery or irradiation followed by replacement therapy

- drugs that block adrenocortical steroid synthesis

24
Q

aminoglutethimide

A
  • inhibits conversion of cholesterol to pregnenolone

- blocks adrenocortical steroid synthesis

25
Q

ketoconazole

A

-inhibits many steps in adrenocortical steroid synthesis

26
Q

metyrapone

A

-inhibitor of 11B hydroxylase (CYP 11B1)

27
Q

etomidate

A

-inhibitor of 11B hydroxylase (CYP 11B1)

28
Q

abiraterone

A

-inhibitor of 17alpha-hydroxylase (CYP17A1)

29
Q

RU486

A

-progesterone and glucocorticoid antagonist

30
Q

dexamethasone as a diagnostic agent

A

in cushing’s syndrome, administering dexamethasone with suppress HPA.

  • tests if axis is working
  • origin of cushing’s. it will suppress cortisol if syndrome is d/t increased ACTH by pituitary. it will NOT suppress cortisol if syndrome is d/t primary adrenocortical hyperfunction or ACTH secretion by tumor or other tissues
31
Q

cushing’s disease

A

increased ACTH secretion by pituitary